FTV – Fortive Corporation

Fortive Corporation Stock Analysis: November 2025 Update

Publication Date: November 03, 2025

Company Overview

Fortive Corporation (NYSE: FTV), headquartered in Everett, Washington, is a prominent entity in the Scientific & Technical Instruments industry, which is part of the broader Technology sector. Founded in 2015, Fortive operates through two primary segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. The company designs, develops, manufactures, and markets an expansive array of products, software, and services that cater to various industries, including manufacturing, healthcare, and communications, primarily under the brand names FLUKE, ACCRUENT, and FLUKE BIOMEDICAL. With total revenue reaching approximately $6.26 billion, Fortive is positioned as a significant player in the market, boasting a diversified portfolio that enables steady revenue streams and a robust competitive stance.

52-Week Price Performance Analysis

Analyzing Fortive’s stock price performance over the past year reveals a predominantly bearish trend. Currently priced at $50.28, the stock has experienced significant fluctuations, with a 52-week high of $62.79 and a low of $45.50. The 52-week chart displays lower highs and lower lows since the peak in February, confirming an ongoing downward trajectory.

Technical Insights

• Support Level: The $50 mark serves as a key support level. Investors will want to monitor this closely, as a decline below this threshold could indicate further weakness.
• Resistance Level: The $60 level appears to be a critical resistance point, suggesting that upward movement may struggle without substantial catalysts.
• Moving Averages: Fortive’s stock price is hovering around the 50-day moving average of $48.80, which has acted as a dynamic resistance. The price’s inability to maintain positions above this moving average, particularly evident from July to August, underscores prevailing bearish sentiment.
• Momentum Indicators: While there was a slight uptick in October, indicating a potential attempt to break through short-term resistance at $50.34, the price remains approximately 5.72% lower than a year ago. Investors should watch for any sustained movement above the moving average and resistance levels that could signal a possible reversal in trend.

Financial Performance and Metrics

Fortive demonstrates solid financial underpinnings, as highlighted by key metrics:

• Total Revenue: Approximately $6.26 billion, which outlines a stable financial foundation.
• EBITDA: Recorded at about $1.68 billion, indicating robust operational profitability. This healthy EBITDA underscores the company’s ability to generate profits from its core operations, thus supporting optimistic future stock performance.

Valuation Metrics:

• Current Stock Price: $50.28
• Target High Price: $66.00
• Target Mean Price: Around $56.69
• Target Low Price: $50.00
• Average Analyst Recommendation: 2.61 (on a scale where a lower number indicates a stronger recommendation to buy).

These metrics suggest a cautiously optimistic view of Fortive, enabling investors to gauge potential profitability against current valuations.

Recent News and Developments

In recent developments, Fortive Corporation completed the spin-off of its Precision Technologies segment, leading to the formation of Ralliant Corporation, which began trading under the symbol “RAL” on June 30, 2025. The market responded with some caution; Fortive’s stock declined to a 52-week low of $51.93, partly due to revenue warnings associated with tariff-related pricing pressures and concerns about customer demand.

Further developments include:

• Earnings Update: For Q3 2025, Fortive reported an adjusted EPS of $0.68, surpassing analyst expectations. Moreover, the company raised its full-year EPS guidance to a range between $2.63 and $2.67.

• Share Repurchase: The announcement of a share repurchase program, allowing for the buyback of 20 million shares, along with a plan to deploy up to $550 million from Ralliant’s cash distribution, adds to shareholder value and reflects management’s confidence in Fortive’s ongoing operations.

Market Sentiment and Analyst Recommendations

The sentiment surrounding Fortive remains cautious among analysts. Out of 16 analysts, the consensus recommendation is to hold, reflecting a balanced view of the current performance trajectory. Despite facing operational challenges, Raymond James has maintained an “Outperform” rating but lowered its price target to $65 from $90, citing ongoing trade-related difficulties.

Analyst Insights

Analysts are projecting:
– Target Mean Price: Approximately $56.69
– Target High Price: $66.00
– Target Low Price: $50.00

The average recommendation of 2.61 implies a moderated outlook with emphasis on holding existing positions rather than pursuing aggressive buying or selling strategies at this juncture.

Conclusion

Fortive Corporation stands as a significant player in the Scientific & Technical Instruments industry, with strong revenue metrics and a solid foundation for growth. However, recent volatility in stock price and concerns over operational pressures indicate that investors should tread carefully. Current share price levels near historical support will be critical for short-term direction.

As Fortive navigates through its operational challenges and seeks to leverage growth opportunities stemming from its recent business adjustments, investors must remain vigilant. The projected target prices and analyst recommendations offer both opportunities for growth and risks that necessitate continuous monitoring of market movements.

Investors are urged to assess ongoing economic conditions and the company’s performance metrics closely before making any subsequent trading decisions.

Metric	Value
Market Cap	$16.0b
Total Debt	$3.4b
Total Cash	$430.8m
Shares Outstanding	317.6m
Float Shares	300.0m